Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo

Generated: December 12, 2017

DrugPatentWatch Database Preview

Etomidate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for etomidate and what is the scope of etomidate freedom to operate?

is the generic ingredient in two branded drugs marketed by Hospira, Aurobindo Pharma Ltd, Emcure Pharms Ltd, Gland Pharma Ltd, Hikma Farmaceutica, Luitpold, Mylan Labs Ltd, Par Sterile Products, West-ward Pharms Int, and Zydus Pharms Usa Inc, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for etomidate. Thirteen suppliers are listed for this compound.

Pharmacology for etomidate

Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia

Medical Subject Heading (MeSH) Categories for etomidate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
LuitpoldETOMIDATEetomidateINJECTABLE;INJECTION078867-001Dec 22, 2009APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdETOMIDATEetomidateINJECTABLE;INJECTION206126-001Feb 24, 2017APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par Sterile ProductsETOMIDATEetomidateINJECTABLE;INJECTION091297-001Jun 20, 2012APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Emcure Pharms LtdETOMIDATEetomidateINJECTABLE;INJECTION204618-001Aug 13, 2014APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraAMIDATEetomidateINJECTABLE;INJECTION018227-001Sep 7, 1982APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Gland Pharma LtdETOMIDATEetomidateINJECTABLE;INJECTION209058-001Apr 18, 2017APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Labs LtdETOMIDATEetomidateINJECTABLE;INJECTION201044-001Feb 7, 2017APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Labs LtdETOMIDATEetomidateINJECTABLE;INJECTION078289-001Jan 2, 2009APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncETOMIDATEetomidateINJECTABLE;INJECTION202360-001Jul 18, 2014APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma FarmaceuticaETOMIDATEetomidateINJECTABLE;INJECTION202354-001Feb 25, 2016APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
US Department of Justice
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: